Pages that link to "Q36938538"
Jump to navigation
Jump to search
The following pages link to Identification of a new JNK inhibitor targeting the JNK-JIP interaction site (Q36938538):
Displaying 50 items.
- JNK1, a potential therapeutic target for hepatocellular carcinoma (Q23912822) (← links)
- Myocilin stimulates osteogenic differentiation of mesenchymal stem cells through mitogen-activated protein kinase signaling (Q24339483) (← links)
- Pathophysiological significance of c-jun N-terminal kinase in acetaminophen hepatotoxicity (Q26799194) (← links)
- JNK signalling in cancer: in need of new, smarter therapeutic targets (Q27023869) (← links)
- Discovery and Characterization of Non-ATP Site Inhibitors of the Mitogen Activated Protein (MAP) Kinases (Q27665974) (← links)
- Structural Mechanisms of Allostery and Autoinhibition in JNK Family Kinases (Q27675044) (← links)
- Discovery of Potent and Selective Covalent Inhibitors of JNK (Q27676927) (← links)
- A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches (Q28392033) (← links)
- Natural intracellular peptides can modulate the interactions of mouse brain proteins and thimet oligopeptidase with 14-3-3ε and calmodulin (Q28573313) (← links)
- Computational modeling of allosteric communication reveals organizing principles of mutation-induced signaling in ABL and EGFR kinases (Q31036423) (← links)
- Role of muscle c-Jun NH2-terminal kinase 1 in obesity-induced insulin resistance (Q33558164) (← links)
- Computational Insights for the Discovery of Non-ATP Competitive Inhibitors of MAP Kinases (Q33593739) (← links)
- Role of the hypothalamic-pituitary-thyroid axis in metabolic regulation by JNK1 (Q33612356) (← links)
- High-throughput screening for modulators of protein–protein interactions: use of photonic crystal biosensors and complementary technologies (Q33765623) (← links)
- Network based analyses of gene expression profile of LCN2 overexpression in esophageal squamous cell carcinoma (Q33789015) (← links)
- Measuring the constitutive activation of c-Jun N-terminal kinase isoforms (Q33835906) (← links)
- Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene (Q33945740) (← links)
- C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress (Q34206209) (← links)
- cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance (Q34285542) (← links)
- Methotrexate-mediated inhibition of nuclear factor κB activation by distinct pathways in T cells and fibroblast-like synoviocytes (Q34727664) (← links)
- Small molecule substrate phosphorylation site inhibitors of protein kinases: approaches and challenges. (Q34992505) (← links)
- c-KIT signaling is targeted by pathogenic Yersinia to suppress the host immune response (Q35037308) (← links)
- Increased sensitivity to apoptosis induced by methotrexate is mediated by JNK. (Q35190872) (← links)
- Design and Characterization of a Potent and Selective Dual ATP- and Substrate-Competitive Subnanomolar Bidentate c-Jun N-Terminal Kinase (JNK) Inhibitor (Q35216258) (← links)
- State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors (Q35738960) (← links)
- JNK pathway signaling: a novel and smarter therapeutic targets for various biological diseases. (Q35822826) (← links)
- Enzyme Kinetics and Interaction Studies for Human JNK1β1 and Substrates Activating Transcription Factor 2 (ATF2) and c-Jun N-terminal kinase (c-Jun) (Q35921571) (← links)
- Evidence that behavioral phenotypes of morphine in β-arr2-/- mice are due to the unmasking of JNK signaling. (Q36035962) (← links)
- Development of JNK2-selective peptide inhibitors that inhibit breast cancer cell migration (Q36107209) (← links)
- Critical role of c-jun N-terminal protein kinase in promoting mitochondrial dysfunction and acute liver injury (Q36221269) (← links)
- From in Silico Discovery to intra-Cellular Activity: Targeting JNK-Protein Interactions with Small Molecules (Q36243062) (← links)
- Small-molecule inhibitors of ERK-mediated immediate early gene expression and proliferation of melanoma cells expressing mutated BRaf (Q36276136) (← links)
- Two hydrophobic residues can determine the specificity of mitogen-activated protein kinase docking interactions (Q36283723) (← links)
- Molecular targets related to inflammation and insulin resistance and potential interventions (Q36294297) (← links)
- Hepatic Cannabinoid Receptor-1 Mediates Diet-Induced Insulin Resistance via Inhibition of Insulin Signaling and Clearance in Mice (Q36351511) (← links)
- Inhibition of JNK mitochondrial localization and signaling is protective against ischemia/reperfusion injury in rats (Q36596206) (← links)
- Endothelial Dysfunction in Human Diabetes Is Mediated by Wnt5a-JNK Signaling. (Q37021140) (← links)
- Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin (Q37031277) (← links)
- Acute and Chronic Hyperglycemia Elicit JIP1/JNK-Mediated Endothelial Vasodilator Dysfunction of Retinal Arterioles (Q37242111) (← links)
- GPCR-like signaling mediated by smoothened contributes to acquired chemoresistance through activating Gli. (Q37493442) (← links)
- Targeting innate immunity protein kinase signalling in inflammation (Q37502685) (← links)
- Signal integration by JNK and p38 MAPK pathways in cancer development (Q37560607) (← links)
- Targeting mitochondrial dysfunction in neurodegenerative disease: Part II. (Q37718248) (← links)
- Mitogen-activated protein kinases in hepatocellular carcinoma development (Q37802466) (← links)
- The Role of JNK Proteins in Metabolism (Q37814784) (← links)
- The Peroxide Dilemma: Opposing and Mediating Insulin Action (Q37828524) (← links)
- The critical role of JNK in the ER‐mitochondrial crosstalk during apoptotic cell death (Q37898067) (← links)
- Druggability Assessment of Protein–Protein Interfaces (Q37958066) (← links)
- The role of the c-Jun N-terminal Kinase signaling pathway in skin cancer (Q38066196) (← links)
- Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways (Q38995223) (← links)